- Adults
- General population
- Elderly
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
Population: General population
Individuals who do not belong to a defined subgroup with specific characteristics, representing the broader population
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antibiotics
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Steroids
- Dexamethasone
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Steroids
- Vitamin D
- Adults
- General population
- Elderly
- Paediatric
- Primary care
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Monoclonal antibodies
- Nirmatrelvir/Ritonavir
- Sotrovimab
- Molnupiravir
- Adults
- General population
- Elderly
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Molnupiravir
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Statins
- Adults
- General population
- Elderly
- Fragile population
- Immunocompromised host
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Nirmatrelvir/Ritonavir
- Molnupiravir
- Adults
- General population
- Elderly
- Fragile population
- Hospital wide
- Emergency department
- Infectious diseases unit
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab
- Bamlanivimab/ Etesevimab
- Adults
- General population
- Elderly
- Fragile population
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Monoclonal antibodies
- Nirmatrelvir/Ritonavir
- Sotrovimab
- Adults
- General population
- Elderly
- Outpatient clinic
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Adults
- General population
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Pharmacological intervention
- Immnunomodulator
- Baricitinib
- Statins
- Simvastatin